🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the safety and activity in the ...
Status
Completed
Location
Arensia Clinical Research Unit
Start Date
2019-08-14
Trial ID
NCT04073498
This study will evaluate the percentage change from baseline in weight afte...
Status
Completed
Location
Handan First Hospital
Start Date
2024-08-14
Trial ID
NCT07020884
Treatments Being Tested
The main purpose of this study is to evaluate the safety and efficacy of on...
Status
Completed
Location
The Second People's Hospital of Hefei
Start Date
2020-12-07
Trial ID
NCT04591626
Treatments Being Tested
Primary Objective: To evaluate, in comparison with placebo, the efficacy o...
Status
Completed
Location
Investigational Site Number 8400006
Start Date
2016-12-21
Trial ID
NCT02921971
The purpose of this study is to evaluate the efficacy and safety of rocatin...
Status
Completed
Location
Cahaba Dermatology and Skin Health Center
Start Date
2023-04-20
Trial ID
NCT05704738
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability and pharmac...
Status
Completed
Location
Quotient Sciences-Miami, Inc
Start Date
2023-06-27
Trial ID
NCT05950906
The purpose of this study is to evaluate safety, tolerability, immunogenici...
Status
Completed
Location
CMAX Clinical Research
Start Date
2020-12-30
Trial ID
NCT05490017
The Phase 1 study described herein will evaluate the safety, tolerability, ...
Status
Recruiting
Location
Xencor Investigative Site
Start Date
2024-10-10
Trial ID
NCT06619990
This is a multi-center, randomized, double blind, placebo-controlled study ...
Status
Unknown
Location
The First Affiliated Hospital of Guangzhou Medical University
Start Date
2022-07-19
Trial ID
NCT06642961
Treatments Being Tested
In asthmatics with airway hyperresponsiveness and a "T2 immune signature" (...
Status
Completed
Location
Firestone Institute for Respiratory Health, St. Joseph's Healthcare
Start Date
2019-07-01
Trial ID
NCT03884842
Treatments Being Tested